- Filed
- May 16, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · May 15, 2023 | 150.44M sh |
| Capex | Q1 2023 · Mar 31, 2023 | $0 |
| Capex | Q1 2023 · Mar 31, 2022 | $7.54K |
| Cash And Equivalents | Q1 2023 · Mar 31, 2023 | $98.53K |
| Cash And Equivalents | Q1 2023 · Dec 31, 2022 | $30.58K |
| Current Liabilities | Q1 2023 · Mar 31, 2023 | $1.3M |
| Current Liabilities | Q1 2023 · Dec 31, 2022 | $729.66K |
| Total Liabilities | Q1 2023 · Mar 31, 2023 | $1.35M |
| Total Liabilities | Q1 2023 · Dec 31, 2022 | $795.72K |
| Current Assets | Q1 2023 · Mar 31, 2023 | $98.53K |
| Current Assets | Q1 2023 · Dec 31, 2022 | $30.58K |
| Total Assets | Q1 2023 · Mar 31, 2023 | $1.51M |
| Total Assets | Q1 2023 · Dec 31, 2022 | $1.22M |
| Operating Cash Flow | Q1 2023 · Mar 31, 2022 | −$724.98K |
| Stockholders Equity | Q1 2023 · Mar 31, 2022 | −$1.74M |
| Stockholders Equity | Q1 2023 · Dec 31, 2021 | −$812.39K |
| Sga Expense restated | Q1 2023 · Mar 31, 2022 | $240.13K |
| Rd Expense | Q1 2023 · Mar 31, 2022 | $397.26K |
| Net Income | Q1 2023 · Mar 31, 2022 | −$922.85K |
| Cost Of Revenue | Q1 2023 · Mar 31, 2022 | $47.12K |